Safe innovation approach: Towards an agile system for dealing with innovations
暂无分享,去创建一个
Christian Micheletti | Araceli Sánchez Jiménez | Stergios Logothetidis | Penny Nymark | Susan Wijnhoven | Cindy Bekker | Roland C. Grafström | Yordan Handzhiyski | Agnes G. Oomen | Isabel Rodriguez-Llopis | Stefania Sabella | Adriënne J.A.M. Sips | Susan Dekkers | Thies Oosterwijk | Annette Kraegeloh | Jacqueline van Engelen | Monique Groenewold | Petra Herbeck-Engel | Cornelle W. Noorlander | Lya G. Soeteman-Hernandez | Blanca Suarez Merino | Isabella Tavernaro | A. Kraegeloh | R. Grafström | S. Sabella | S. Logothetidis | M. Apostolova | A. Oomen | A. Sips | C. Micheletti | S. Wijnhoven | S. Dekkers | M. Groenewold | A. S. Jiménez | P. Nymark | V. Karagkiozaki | J. V. Engelen | Isabella Tavernaro | C. Noorlander | Varvara Karagkiozaki | Margarita D. Apostolova | Karl Hoehener | Sean Kelly | C. Bekker | Y. Handzhiyski | T. Oosterwijk | S. Kelly | L. Soeteman-Hernández | P. Herbeck‐Engel | I. Rodríguez-Llopis | Karl Hoehener
[1] Eugenia Valsami-Jones,et al. A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design NMs , 2014 .
[2] Trevor Kletz. Inherently Safer Design—Its Scope and Future , 2003 .
[3] Georgia Tsiliki,et al. The eNanoMapper database for nanomaterial safety information , 2015, Beilstein journal of nanotechnology.
[4] Evan S. Michelson. “The Train Has Left the Station”: The Project on Emerging Nanotechnologies and the Shaping of Nanotechnology Policy in the United States , 2013 .
[5] Nastassja A. Lewinski,et al. Nanocuration workflows: Establishing best practices for identifying, inputting, and sharing data to inform decisions on nanomaterials , 2015, Beilstein journal of nanotechnology.
[6] G. Schmid. The Nature of Nanotechnology , 2010 .
[7] Hermann M. Bolt. Grouping of nanomaterials for risk assessment , 2014, Archives of Toxicology.
[8] David H. Guston,et al. The Anticipatory Governance of Emerging Technologies , 2010 .
[9] Hedwig M Braakhuis,et al. Grouping nanomaterials to predict their potential to induce pulmonary inflammation. , 2016, Toxicology and applied pharmacology.
[10] Robert G. Cooper,et al. Perspective: The Stage‐Gate® Idea‐to‐Launch Process—Update, What's New, and NexGen Systems* , 2008 .
[11] Riego Sintes Juan,et al. NANoREG harmonised terminology for environmental health and safety assessment of nanomaterials , 2016 .
[12] Iseult Lynch,et al. How safe are nanomaterials? , 2015, Science.
[13] Tsuyoshi Murata,et al. {m , 1934, ACML.
[14] Antonio Marcomini,et al. Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials , 2015, International journal of environmental research and public health.
[15] Pekka Kohonen,et al. Toxic and Genomic Influences of Inhaled Nanomaterials as a Basis for Predicting Adverse Outcome. , 2018, Annals of the American Thoracic Society.
[16] Katarzyna Odziomek,et al. Decision tree models to classify nanomaterials according to the DF4nanoGrouping scheme , 2018, Nanotoxicology.
[17] Andreas Luch,et al. Systems Biology to Support Nanomaterial Grouping. , 2017, Advances in experimental medicine and biology.
[18] Finn Verner Jensen,et al. Bayesian networks , 1998, Data Mining and Knowledge Discovery Handbook.
[19] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[20] Arthur N. Mayeno,et al. Computational Toxicology , 2013, Methods in Molecular Biology.
[21] Pantelis Sopasakis,et al. Jaqpot Quattro: A Novel Computational Web Platform for Modeling and Analysis in Nanoinformatics , 2017, J. Chem. Inf. Model..
[22] Evan S. Michelson. Emerging technologies and the role of NGOs. , 2017, Nature nanotechnology.
[23] ScienceDirect,et al. Toxicology and Applied Pharmacology , 1959, Nature.
[24] S. Thompson. Advances in experimental medicine and biology , 1996 .
[25] Seyed Hamed Mousavi,et al. Process Safety and Environmental Protection , 2015 .
[26] Christian Micheletti,et al. Implementation of Safe-by-Design for Nanomaterial Development and Safe Innovation: Why We Need a Comprehensive Approach , 2018, Nanomaterials.
[27] Tomasz Puzyn,et al. How should the completeness and quality of curated nanomaterial data be evaluated? , 2016, Nanoscale.
[28] Deutsche Gesellschaft für experimentelle und klinische Phar Toxikologie.. Archives of toxicology , 1974 .
[29] T. Schimmel. Beilstein Journal of Nanotechnology , 2010, Beilstein journal of nanotechnology.
[30] Milind Kandlikar,et al. Expert Views on Regulatory Preparedness for Managing the Risks of Nanotechnologies , 2013, PloS one.
[31] L. Christophorou. Science , 2018, Emerging Dynamics: Science, Energy, Society and Values.
[32] Ola Spjuth,et al. Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of ‘Omics’ Data from Human Cell Cultures , 2015, Alternatives to laboratory animals : ATLA.
[33] Sharon Munn,et al. The Adverse Outcome Pathway approach in nanotoxicology , 2017 .
[34] D. Rebholz-Schuhmann,et al. Journal of Biomedical Semantics , 2017 .
[35] Egon L. Willighagen,et al. eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment , 2015, Journal of Biomedical Semantics.
[36] Vidar Skaug,et al. Criteria for grouping of manufactured nanomaterials to facilitate hazard and risk assessment, a systematic review of expert opinions , 2018, Regulatory toxicology and pharmacology : RTP.
[37] Yi-Ming Wei,et al. Author's Personal Copy China's Carbon Emissions from Urban and Rural Households during 1992e2007 , 2022 .
[38] S. Buck,et al. Solving reproducibility , 2015, Science.
[39] Gregory Morose,et al. The 5 principles of “Design for Safer Nanotechnology” , 2010 .
[40] Paul Anastas,et al. Green chemistry: principles and practice. , 2010, Chemical Society reviews.